Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07231159 · ClinicalTrials.gov registry record

Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots

A clinical trial of Breast Cancer and Prostate Cancer, sponsored by AdventHealth.

Recruiting
Registry status
200
Enrollment target
1
Study location

NCT07231159 is a study of Breast Cancer and Prostate Cancer that is actively recruiting participants, run by AdventHealth. The registered enrollment target is 200 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07231159, a study of Breast Cancer and Prostate Cancer, is actively recruiting participants, sponsored by AdventHealth.

RECRUITING
Registry status
200 participants
Enrollment target
1
Study location

Study Summary

To evaluate a community-based outreach initiative for screening, diagnosis, and treatment of breast, lung, and prostate cancers in underserved adults using the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) implementation science framework.

Interventions

  • BEHAVIORAL referral for definitive diagnosis based on their cancer screening results
  • BEHAVIORAL Engagement

Study Locations (1)

Florida

  • Adventhealth - Orlando

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2025-11-17
Est. Completion 2026-08-31

Sponsor

AdventHealth

95 total trials

What the Registry Record Tells You About NCT07231159

The ClinicalTrials.gov registry entry for NCT07231159 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (93% lower). The listed sponsor is AdventHealth, which has 95 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which referral for definitive diagnosis based on their cancer screening results is the first listed.

NCT07231159 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT07231159 about?

NCT07231159 is a clinical study titled "Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots". To evaluate a community-based outreach initiative for screening, diagnosis, and treatment of breast, lung, and prostate cancers in underserved adults using the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) implementation science framework.

What is the current status of trial NCT07231159?

This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2025-11-17. Estimated completion is 2026-08-31.

What conditions does trial NCT07231159 study?

This clinical trial studies the following conditions: Breast Cancer, Prostate Cancer, Lung Cancer (Diagnosis).

What interventions are being tested in trial NCT07231159?

The interventions under investigation include: referral for definitive diagnosis based on their cancer screening results (BEHAVIORAL), Engagement (BEHAVIORAL).

Who is sponsoring clinical trial NCT07231159?

This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07231159 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.